Recognize and celebrate exceptional achievements in the pharmaceutical industry at Reuters Events Pharma Awards Europe 2024. Scheduled for April 16, 2024, this event focuses on rewarding those enhancing patient outcomes, creating customer value, and addressing health inequities. Unlike other ceremonies, these awards acknowledge value-driven contributions. If your team has made extraordinary strides, seize the opportunity to showcase your success in one of the six value-based categories. Let the world hear about your impactful work and be part of an event that highlights meaningful contributions to healthcare. Don't miss the chance to share your accomplishments and inspire the industry to reach new heights! 

[Read on register.reutersevents.com](https://register.reutersevents.com/event/651785c4-c899-4a20-abc4-d78506041c02/regPage:916dc9f7-dae8-4452-bd5c-cd6202dbe92a)

Pharma's role within the healthcare system is under pressure due to increased demand, regulatory changes, and a growing access gap. The Reuters Events: Pharma 2024 conference, taking place in Barcelona from April 16 to April 18, 2024, brings together over 1,200 pharma professionals from various functions to collaborate on shaping the future of the industry. Together, they aim to align internal efforts, enhance value propositions, and solidify pharma's position in healthcare. The event focuses on becoming a trusted source for scientific information, leveraging digital capabilities for patient outcomes, adapting to evolving legislation, and harnessing data to meet patient needs. Tickets are available at different pricing tiers, catering to various participant categories.

 [Read on reutersevents.com](https://reutersevents.com/#about)

The International Conference on Science, Health, and Medicine (ICSHM) is a prestigious gathering aimed at providing a global platform for academicians, researchers, engineers, industry professionals, and students to exchange their research findings with experts worldwide. Scheduled for April 16th-17th, 2024, in Boston, USA, the conference facilitates in-person interaction, fostering collaboration, and establishing international connections for future endeavors. Organized by The International Society for Engineers and Researchers (ISER), ICSHM features invited lectures by renowned speakers and recognizes outstanding contributions with Best Paper Awards. Through this event, significant advancements are anticipated in the fields of science, health, and medicine.

Read on iser.co

ICSHM 2024, slated for April 16th - 17th in Boston, USA, stands as a premier platform uniting scholars, researchers, engineers, and students worldwide to exchange research insights. Facilitated by the International Society for Engineers and Researchers (ISER), the conference fosters networking opportunities, encouraging global participants to share ideas, build connections, and forge international collaborations. This esteemed event aims to enrich the scientific landscape by offering a forum for sharing cutting-edge discoveries, hosting invited lectures, and awarding top papers for their impactful contributions, aiming to advance knowledge in diverse scientific domains.
 

Read on iser.co

The ICRAMHS 2024, scheduled for April 16th - 17th in New York, USA, aims to unite prominent scientists, scholars, and researchers to exchange insights on diverse aspects of Medical and Health Sciences. This interdisciplinary conference serves as a prominent platform for presenting recent innovations, discussing emerging trends, and addressing practical challenges encountered in these fields. Authors are invited to submit their original research papers, abstracts, and e-posters. Accepted contributions will undergo blind peer review and published in the International Science Index. Proceedings will be indexed in renowned databases like Thomson Reuters, SCOPUS, and ProQuest, ensuring global exposure for scholarly works.

Read on academicsworld.org

The 5th Dermatology Drug Development Summit Europe convenes on April 16-18, 2024, focusing on advancing beyond symptomatic treatments. It aims to uncover targetable pathways, translational techniques, and navigate European healthcare infrastructure to enhance R&D for small molecules, biologics, mAbs, and more. With a focus on addressing barriers in pipeline progression and patient access, this industry-led forum unites large pharma, biotech, academic, and clinician KOLs. The event aims to translate innovative R&D into durable therapies for inflammatory-mediated dermatological diseases, ensuring superior efficacy and safety while improving patient quality of life within the intricate European healthcare landscape.

 [Read on dermatology-drugdevelopment](https://dermatology-drugdevelopment-europe.com/)

The 4th Fc-Mediated Function Summit, scheduled from April 16 to 18, 2024, offers a unique opportunity to delve into the transformative potential of FcRn in autoimmune and immuno-oncology (IO) realms. This specialized conference focuses on understanding targets and biology related to FcRn, FcγR, and IgG, aiming to advance molecular development and therapeutic applications. With a spotlight on molecular engineering and clinical outcomes, attendees gain unparalleled insights into critical targets like FcRn and FcγR. Moreover, the summit fosters exceptional networking opportunities, facilitating cross-disciplinary partnerships and knowledge exchange among professionals in immunology, antibody engineering, pharmacology, and immuno-oncology.

 [Read on fc-function-summit.com](https://fc-function-summit.com/take-part/register/)

The 4th Fc-Mediated Function Summit, scheduled from April 16 to April 18, 2024, focuses on advancing therapeutic frontiers in FcRn, FcγR, and IgG domains. With the recent FcRn inhibitor approval in 2023 validating Fc receptors in autoimmunity and immuno-oncology, the summit targets Fc-engineering strategies in antibody design. Experts from pharma and biotech explore FcRn's potential over traditional therapies, like corticosteroids and immunosuppressants. The event, driven by industry discussions and networking, assesses FcRn's transformative capacity, signaling a shift in research towards Fc-mediated therapeutic approaches for IgG, antibody, and FcRn-agonist drugs. 

[Read on fc-function-summit.com](https://fc-function-summit.com/)

The updated ICH Q14 guidance by the FDA has raised the bar for product quality expectations in release and stability testing. The 3rd ADC Analytical Development conference, scheduled for Tue, 16 Apr 2024 - Thu, 18 Apr 2024, addresses this evolution. It offers a technical exploration into optimizing physiochemical methods to quantify drug-to-antibody ratio (DAR) and distribution, size and charge variants, bioassays for potency understanding, and impurity assays. Engage with 100+ experts from leading organizations like Daiichi Sankyo, Eli Lilly, and AstraZeneca to gain comprehensive insights for producing high-quality, regulatory-compliant antibody-drug conjugates (ADCs). This event fosters collaboration, addresses analytical challenges, and navigates future regulatory clarity for ADC experts.

 [Read on adc-analytical.com](https://adc-analytical.com/)

Since 2017, the MedHealth Summit has revolutionized healthcare innovation in Michigan and Ontario. Mark your calendars for April 16, 2024, for a day packed with inspiring speakers and curated matchmaking—all at no cost to attendees. Join our inclusive healthcare ecosystem and stay tuned for early 2024 registration. Share topic ideas, host matchmaking meetings, or become a sponsor in the meantime.

Read on medhealthinnovation.org